ASCO Board of Directors Convened for Summer Board Meeting and Inaugural Annual Meeting in Denver

On June 19 in Denver, Colorado, ASCO’s Board gathered for its summer Board of Directors meeting.

Several important items were discussed:

  • The Board elected to keep the FY2018 Executive Committee the same for FY19.
  • Recent National Board of Examiners in Optometry updates and communications regarding national pass rate reporting and the joint ASCO-NBEO Board meeting scheduled for March 2019.
  • Continuing Education accreditation negotiations between the AAO, ARBO, ASCO and AOA which also included an ASCO – ARBO agreement regarding a members-only discount on COPE fees.
  • Progress made by the Applicant Pool Development Task Force working on increasing the quality and quantity of prospective students. Of particular note, the Board agreed to use the salary information provided by AOA’s salary survey to ensure consistency and avoid misinformation when using salary data.
  • An update was given on ASCO’s Strategic Plan and the Board was asked to prioritize and finalize priorities and work plans for the coming year. The Executive Committee met in August to discuss budget ramifications.

Updates were also given by several ASCO committees. The Financial Affairs and Audit committees approved the investment advisor and auditor respectively.

Two Corporate Contributors, Mr. Mark Risher, Senior Manager, Optometric Academic Development with Allergan, and Mr. Kevin McNaught, National Strategic Accounts Manager with Diopsys, Inc. gave presentations.

ASCO’s next Board Meeting will be held in San Antonio, Texas on Nov. 6.